SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
--------------
Date of Report (Date of earliest event reported): December 19, 2002
ORCHID BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-30267 22-3392819
- ---------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
4390 US Route One
Princeton, NJ 08540
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (609) 750-2200
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On December 20, 2002, Orchid BioSciences, Inc. announced that it had
entered into a definitive agreement with Beckman Coulter, Inc. pursuant to which
Beckman acquired certain assets of Orchid's SNP genotyping instruments,
bioinformatic software and related consumables business. The press release
regarding the acquisition attached hereto as Exhibit 99.1 is incorporated herein
by reference into this Item 5.
In addition, on December 27, 2002, Orchid announced that it had
obtained a $10 million credit facility from Comerica, a leading financial
services company. The press release regarding the credit facility attached
hereto as Exhibit 99.2 is incorporated herein by reference into this Item 5.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release, dated December 20, 2002, announcing the
acquisition of Orchid's SNP Geneotyping Instrumentation
Business by Beckman Coulter, Inc.
99.2 Press Release, dated December 27, 2002, announcing Orchid's
obtaining $10 million credit facility from Comerica.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORCHID BIOSCIENCES, INC.
(Registrant)
Date: January 6, 2003 /s/ Andrew P. Savadelis
------------------------------------
Name: Andrew P. Savadelis
Title: Senior Vice President & Chief
Financial Officer
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
99.1 Press Release, dated December 20, 2002, announcing
the acquisition of Orchid's SNP Genotyping
Instrumentation Business by Beckman Coulter, Inc.
99.2 Press Release, dated December 27, 2002, announcing
Orchid's obtaining $10 million credit facility
from Comerica.